Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

119
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
119
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination therapy of levodopa with safinamide is more effective than with rasagiline and zonisamide in Asian Parkinson's disease patients with motor fluctuations: a systematic review and network meta-analysis of randomized controlled trials.

Journal of neurology·2026
Same author

Blood and brain tissue RNA transcriptomics reveal six potential targets of Parkinson's disease: a meta-analysis.

Journal of advanced research·2026
Same author

Three Years of a New Multidisciplinary Adult Neurogenetics Clinic in Singapore.

Neurology. Genetics·2026
Same author

Reader Response: Association of Relative Brain Hyperperfusion Independent of Dopamine Depletion With Motor Dysfunction in Patients With Parkinson Disease.

Neurology·2026
Same author

Examination of shared gut microbiome signatures in aging and Parkinson's disease.

Frontiers in aging neuroscience·2026
Same author

CSF1R T567M mutation induces microglial dysfunction and synaptic impairment in patient iPSC-derived cerebral organoids of CSF1R-related disorder.

Cell death discovery·2026

Related Experiment Video

Updated: Apr 15, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.1K

Evaluating LRRK2 genetic variants with unclear pathogenicity.

Fathima Shaffra Refai1, Shin Hui Ng1, Eng-King Tan1

  • 1Department of Neurology, National Neuroscience Institute, 7 Hospital Drive, Outram Road, Singapore 169611.

Biomed Research International
|March 31, 2015
PubMed
Summary

Five leucine-rich repeat kinase 2 (LRRK2) variants negatively impact cell survival and increase kinase activity, suggesting a gain-of-function mechanism in Parkinson's disease (PD) pathogenesis.

More Related Videos

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

23.1K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.5K

Related Experiment Videos

Last Updated: Apr 15, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.1K
Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

23.1K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.5K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in leucine-rich repeat kinase 2 (LRRK2) are a significant genetic factor in Parkinson's disease (PD).
  • The pathogenicity of many LRRK2 variants remains uncertain due to their presence in both patients and healthy controls.

Purpose of the Study:

  • To investigate the pathogenic potential of five specific LRRK2 exonic variants (L1165P, T1410M, M1646T, L2063X, Y2189C).
  • To analyze the association of these variants with cellular function and kinase activity in vitro.

Main Methods:

  • Incorporation of point mutations representing the five selected LRRK2 variants into the LRRK2 gene.
  • In vitro functional assays measuring cell survival under stress and LRRK2 kinase activity.
  • Comparison of variant effects against wild-type LRRK2.

Main Results:

  • All five LRRK2 variants significantly reduced cell survival, both with and without applied stress, compared to wild-type.
  • Most variants exhibited a slight increase in kinase activity relative to wild-type.
  • A negative correlation was observed between cell survival and kinase activity.

Conclusions:

  • The studied LRRK2 variants, despite differing locations, appear to contribute to pathogenicity.
  • An increased kinase activity, supporting a gain-of-function mechanism, is suggested as the likely pathogenic pathway for these variants in Parkinson's disease.